- Home
- CRDF vs ARBE Comparison
CRDF vs ARBE Comparison
Compare CRDF & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ARBE
- Stock Information
- Founded
- CRDF 1999
- ARBE 2015
- Country
- CRDF United States
- ARBE Israel
- Employees
- CRDF N/A
- ARBE N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ARBE EDP Services
- Sector
- CRDF Health Care
- ARBE Technology
- Exchange
- CRDF Nasdaq
- ARBE Nasdaq
- Market Cap
- CRDF 233.5M
- ARBE 203.2M
- IPO Year
- CRDF N/A
- ARBE N/A
- Fundamental
- Price
- CRDF $4.04
- ARBE $1.56
- Analyst Decision
- CRDF Strong Buy
- ARBE Buy
- Analyst Count
- CRDF 6
- ARBE 2
- Target Price
- CRDF $11.92
- ARBE $1.75
- AVG Volume (30 Days)
- CRDF 1.5M
- ARBE 1.5M
- Earning Date
- CRDF 08-07-2025
- ARBE 08-05-2025
- Dividend Yield
- CRDF N/A
- ARBE N/A
- EPS Growth
- CRDF N/A
- ARBE N/A
- EPS
- CRDF N/A
- ARBE N/A
- Revenue
- CRDF $587,000.00
- ARBE $671,000.00
- Revenue This Year
- CRDF N/A
- ARBE $285.16
- Revenue Next Year
- CRDF N/A
- ARBE $370.11
- P/E Ratio
- CRDF N/A
- ARBE N/A
- Revenue Growth
- CRDF N/A
- ARBE N/A
- 52 Week Low
- CRDF $2.01
- ARBE $0.85
- 52 Week High
- CRDF $5.64
- ARBE $5.09
- Technical
- Relative Strength Index (RSI)
- CRDF 65.93
- ARBE 45.68
- Support Level
- CRDF $3.07
- ARBE $1.43
- Resistance Level
- CRDF $4.22
- ARBE $1.80
- Average True Range (ATR)
- CRDF 0.22
- ARBE 0.12
- MACD
- CRDF 0.08
- ARBE -0.02
- Stochastic Oscillator
- CRDF 87.35
- ARBE 25.10
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.